Fundz

Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer

PUBLIC · PRMEApr 16, 2026

Position

Chief Financial Officer

Company

Prime Medicine

Svetlana Makhni
CambridgeBiotechnologyHealth CareGeneticsTherapeutics

Description

Prime Medicine has announced the appointment of Svetlana Makhni as Chief Financial Officer. She will oversee the company's financial operations and strategy, leveraging her extensive experience in biotechnology and healthcare.

Other recent leadership changes in Genetics and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Prime Medicine, and when

A new leader at Prime Medicine brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Prime Medicine raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Prime Medicine, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Prime Medicine. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Prime Medicine

Location

Cambridge, Massachusetts, United States

About

Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is deploying its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated one-time curative genetic therapies. Designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications, Prime Editors have the potential to repair almost all types of genetic mutations and work in many different tissues, organs and cell types. Taken together, Prime Editing’s versatile gene editing capabilities could unlock opportunities across thousands of potential indications.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Prime Medicine changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Allan
Likely contact at this company
••••••••@••••••••

See Allan's verified email →

Steve
Likely contact at this company
••••••••@••••••••

See Steve's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Prime Medicine's next move

Learn about Strategic plan

Prime Medicine changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.